The regulatory community is hell bent on increasing transparency into the derivatives market by any means necessary, including forcing OTC instruments to be cleared via central counterparties (CCPs) and requiring firms to report more data to new trade repositories. A-Team Insight speaks to Steve Ingle, derivatives product manager at BNY Mellon Asset Servicing, to find out how all of these changes are impacting the way firms deal with data.

Want to know what we have to say about this? Get free access to this and more stories by signing up for a free trial (or free access if you work at a financial institution) with no obligation below, or login if you’re already a member

Existing Users Login

Sign up for Complimentary Access or Subscribe to Read this Article

For instant access to our A-Team Insight content, you can sign up for 30-day complimentary access to the full content of our news services. This will enable you to read the latest in-depth analysis on the stories that matter to you, access and search our full archives, and receive the latest monthly issue of A-Team Insight in convenient PDF format.

You may qualify for annual complimentary access if you are a senior manager at a financial institution (bank, brokerage, asset management firm, etc.).

For more information or to register, CLICK HERE for instant complimentary access.

Already like what you've seen and know you want to subscribe? An annual subscription is priced at £495/$795 and gives full access for up to three people to all our online content and the monthly A-Team Insight digest of the top news in PDF format. CLICK HERE to subscribe now.